Liontrust Investment Partners’s Eli Lilly LLY Stock Holding History

Liontrust Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.3M	Buy	30,753 +9,788	+47%	+$9.92M	0.48%	57
2025 Q4	$22.5M	Sell	20,965 -32,891	-61%	-$31.4M	0.33%	66
2025 Q3	$41.1M	Sell	53,856 -1,204	-2%	-$896K	0.6%	48
2025 Q2	$42.9M	Buy	55,060 +23,501	+74%	+$18.3M	0.61%	46
2025 Q1	$26.1M	Sell	31,559 -7,686	-20%	-$6.4M	0.41%	55
2024 Q4	$30.3M	Buy	39,245 +13,745	+54%	+$11.4M	0.44%	50
2024 Q3	$23.1M	Hold	25,500	–	–	0.33%	59
2024 Q2	$23.1M	Buy	25,500 +3,000	+13%	+$2.4M	0.33%	59
2024 Q1	$17.5M	Sell	22,500 -10,500	-32%	-$7.47M	0.24%	74
2023 Q4	$19.2M	Buy	33,000 +17,500	+113%	+$10.2M	0.28%	62
2023 Q3	$8.33M	Buy	+15,500	New	+$7.99M	0.13%	98

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Liontrust Investment Partners's LLY Position: Q1 2026 in Review

Liontrust Investment Partners increased its Eli Lilly (LLY) stake by 47% in Q1 2026, buying an estimated $9.92M and bringing the position to 30,753 shares worth $28.3M. The position accounts for 0.48% of the portfolio, ranked #57.

Liontrust Investment Partners first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $42.9M in Q2 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Liontrust Investment Partners held 30,753 shares of Eli Lilly worth $28.3M as of Q1 2026.
Liontrust Investment Partners bought 9,788 Eli Lilly shares in Q1 2026, an estimated $9.92M.
Eli Lilly made up 0.48% of Liontrust Investment Partners's portfolio in Q1 2026, its #57 holding.
Liontrust Investment Partners first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
Liontrust Investment Partners's Eli Lilly position peaked at $42.9M in Q2 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Liontrust Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.